Definitive Healthcare Corp Stock Analysis
| DH Stock | USD 2.31 0.01 0.43% |
Definitive Healthcare Corp is undervalued with Real Value of 2.69 and Target Price of 4.03. The main objective of Definitive Healthcare stock analysis is to determine its intrinsic value, which is an estimate of what Definitive Healthcare Corp is worth, separate from its market price. There are two main types of Definitive Healthcare's stock analysis: fundamental analysis and technical analysis.
The Definitive Healthcare stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Definitive Healthcare's ongoing operational relationships across important fundamental and technical indicators.
Definitive | Build AI portfolio with Definitive Stock |
Definitive Stock Analysis Notes
About 94.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 1.72. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Kevin Coop at 508 720 4224 or check out https://www.definitivehc.com.Definitive Healthcare Quarterly Total Revenue |
|
Definitive Healthcare Investment Alerts
| Definitive Healthcare generated a negative expected return over the last 90 days | |
| Definitive Healthcare has high historical volatility and very poor performance | |
| Definitive Healthcare has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 203.3 M. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: What drives Definitive Healthcare Corp stock price - Straddle and Strangle Trades Free Stay Ahead With Picks - earlytimes.in |
Definitive Healthcare Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Definitive Largest EPS Surprises
Earnings surprises can significantly impact Definitive Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-26 | 2024-12-31 | 0.0718 | 0.08 | 0.0082 | 11 | ||
2025-11-06 | 2025-09-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2024-02-28 | 2023-12-31 | 0.08 | 0.07 | -0.01 | 12 |
Definitive Healthcare Environmental, Social, and Governance (ESG) Scores
Definitive Healthcare's ESG score is a quantitative measure that evaluates Definitive Healthcare's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Definitive Healthcare's operations that may have significant financial implications and affect Definitive Healthcare's stock price as well as guide investors towards more socially responsible investments.
Definitive Healthcare Thematic Classifications
In addition to having Definitive Healthcare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Health ManagementHealthcare providers, hospitals | |
![]() | ManagementManagement services |
Definitive Stock Institutional Investors
| Shares | Bank Of America Corp | 2025-06-30 | 769.4 K | New York State Common Retirement Fund | 2025-06-30 | 766.4 K | Renaissance Technologies Corp | 2025-06-30 | 703.4 K | Aqr Capital Management Llc | 2025-06-30 | 665 K | Ubs Group Ag | 2025-06-30 | 476.3 K | Charles Schwab Investment Management Inc | 2025-06-30 | 402.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 361 K | Northern Trust Corp | 2025-06-30 | 345.5 K | Citadel Advisors Llc | 2025-06-30 | 333.1 K | Advent International Lp | 2025-06-30 | 62.5 M | Goldman Sachs Group Inc | 2025-06-30 | 8.7 M |
Definitive Market Capitalization
The company currently falls under 'Small-Cap' category with a market capitalization of 240.44 M.Definitive Profitablity
The company has Net Profit Margin (PM) of (0.78) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.06) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.06.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.04) | (1.09) | |
| Return On Capital Employed | (0.77) | (0.73) | |
| Return On Assets | (0.38) | (0.36) | |
| Return On Equity | (0.93) | (0.88) |
Management Efficiency
The current Return On Tangible Assets is estimated to decrease to -1.09. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.73. As of now, Definitive Healthcare's Fixed Asset Turnover is decreasing as compared to previous years. The Definitive Healthcare's current Asset Turnover is estimated to increase to 0.24, while Net Tangible Assets are projected to decrease to (682 M). Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.21 | 4.95 | |
| Tangible Book Value Per Share | (0.72) | (0.76) | |
| Enterprise Value Over EBITDA | (1.11) | (1.05) | |
| Price Book Value Ratio | 1.08 | 1.02 | |
| Enterprise Value Multiple | (1.11) | (1.05) | |
| Price Fair Value | 1.08 | 1.02 | |
| Enterprise Value | 627.1 M | 595.8 M |
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Technical Drivers
As of the 14th of December 2025, Definitive Healthcare shows the Standard Deviation of 3.58, variance of 12.84, and Mean Deviation of 2.65. Definitive Healthcare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Definitive Healthcare Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Mid-point over period is an average of Definitive Healthcare highest and lowest values attained during the given period.
Definitive Healthcare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Definitive Healthcare Outstanding Bonds
Definitive Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Definitive Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Definitive bonds can be classified according to their maturity, which is the date when Definitive Healthcare Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Definitive Healthcare Predictive Daily Indicators
Definitive Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Definitive Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Definitive Healthcare Forecast Models
Definitive Healthcare's time-series forecasting models are one of many Definitive Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Definitive Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Definitive Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Definitive Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Definitive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Definitive Healthcare. By using and applying Definitive Stock analysis, traders can create a robust methodology for identifying Definitive entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (2.51) | (2.39) | |
| Operating Profit Margin | (2.82) | (2.68) | |
| Net Loss | (1.64) | (1.56) | |
| Gross Profit Margin | 0.78 | 0.57 |
Current Definitive Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Definitive analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Definitive analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 4.03 | Buy | 14 | Odds |
Most Definitive analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Definitive stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Definitive Healthcare, talking to its executives and customers, or listening to Definitive conference calls.
Definitive Stock Analysis Indicators
Definitive Healthcare Corp stock analysis indicators help investors evaluate how Definitive Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Definitive Healthcare shares will generate the highest return on investment. By understating and applying Definitive Healthcare stock analysis, traders can identify Definitive Healthcare position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 131 M | |
| Total Stockholder Equity | 444.4 M | |
| Capital Lease Obligations | 10 M | |
| Property Plant And Equipment Net | 11.3 M | |
| Cash And Short Term Investments | 290.2 M | |
| Cash | 105.4 M | |
| 50 Day M A | 2.8184 | |
| Net Interest Income | -245 K | |
| Total Current Liabilities | 161.2 M | |
| Forward Price Earnings | 8.5179 | |
| Investments | -26.4 M | |
| Interest Expense | 14.8 M | |
| Stock Based Compensation | 38.1 M | |
| Long Term Debt | 229.4 M | |
| Common Stock Shares Outstanding | 116.6 M | |
| Total Cashflows From Investing Activities | -26.4 M | |
| Tax Provision | -42.3 M | |
| Accounts Payable | 10.8 M | |
| Net Debt | 147.7 M | |
| Other Operating Expenses | 963 M | |
| Non Current Assets Total | 719.2 M | |
| Liabilities And Stockholders Equity | 1.1 B | |
| Non Currrent Assets Other | 16.7 M |
Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |

